Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Randomized Double-blind Clinical Trial of BCD-100 Plus Platinum-based Chemotherapy With and Without Bevacizumab Versus Placebo Plus Platinum-based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer

NCT03912415 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT03912415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Randomized Double-blind Clinical Trial of BCD-100 Plus Platinum-based Chemotherapy With and Without Bevacizumab Versus Placebo Plus Platinum-based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2019
Completion date
December 1, 2024
Enrollment
316 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer